• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活剂在人胃癌细胞系(AGS)中的过表达可诱导严重联合免疫缺陷小鼠产生致瘤性。

Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.

作者信息

Choi Yang-Kyu, Yoon Byung-Il, Kook Yoon-Hoh, Won Young-Suk, Kim Jin-Hyun, Lee Chul-Ho, Hyun Byung-Hwa, Oh Goo-Taeg, Sipley John, Kim Dae-Yong

机构信息

Korea Research Institute of Bioscience and Biotechnology, Taejon, 305-333, Korea.

出版信息

Jpn J Cancer Res. 2002 Feb;93(2):151-6. doi: 10.1111/j.1349-7006.2002.tb01253.x.

DOI:10.1111/j.1349-7006.2002.tb01253.x
PMID:11856478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5926960/
Abstract

The significance of urokinase-type plasminogen activator (uPA) expression in gastric cancer development was tested by using a human uPA cDNA transfection approach and an in vivo severe combined immunodeficient (SCID) mouse model. The AGS gastric cancer cell line, which has urokinase-type plasminogen-activator receptor (uPAR) but lacks uPA, was transfected with a plasmid containing human uPA cDNA and injected into the backs of SCID mice. Compared with the parent AGS cells, uPA protein secretion in AGS-2-, AGS-4-, and AGS-8-transfected cells increased by 26.1-, 34.6-, and 4.8-fold, respectively (P < 0.05). mRNA expression levels of uPA in the AGS-4 clone were much stronger than those in AGS-2 and AGS-8 clones. After the cancer cells (2 x 10(6)) were injected s.c. into the SCID mice, a palpable mass was observed at the injection site at around 140 days post-injection, followed by accelerated growth of the xenograft up to 180 days post-injection only in the high uPA-producing clone (AGS-4). These results suggest that continuous and high production of uPA by tumor cells is one of the important factors reflecting the malignancy of gastric cancer cells.

摘要

通过使用人尿激酶型纤溶酶原激活剂(uPA)cDNA转染方法和体内严重联合免疫缺陷(SCID)小鼠模型,测试了uPA表达在胃癌发展中的意义。将含有尿激酶型纤溶酶原激活剂受体(uPAR)但缺乏uPA的AGS胃癌细胞系用含有人uPA cDNA的质粒转染,并注射到SCID小鼠的背部。与亲本AGS细胞相比,AGS-2、AGS-4和AGS-8转染细胞中的uPA蛋白分泌分别增加了26.1倍、34.6倍和4.8倍(P < 0.05)。AGS-4克隆中uPA的mRNA表达水平比AGS-2和AGS-8克隆中的要强得多。将癌细胞(2×10⁶)皮下注射到SCID小鼠体内后,在注射后约140天时在注射部位观察到可触及的肿块,随后仅在高uPA产生克隆(AGS-4)中,异种移植在注射后180天内加速生长。这些结果表明,肿瘤细胞持续高产量产生uPA是反映胃癌细胞恶性程度的重要因素之一。

相似文献

1
Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.尿激酶型纤溶酶原激活剂在人胃癌细胞系(AGS)中的过表达可诱导严重联合免疫缺陷小鼠产生致瘤性。
Jpn J Cancer Res. 2002 Feb;93(2):151-6. doi: 10.1111/j.1349-7006.2002.tb01253.x.
2
Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.巨噬细胞抑制细胞因子-1通过上调尿激酶型纤溶酶原激活系统诱导胃癌细胞的侵袭性。
Cancer Res. 2003 Aug 1;63(15):4648-55.
3
Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).可溶性尿激酶型纤溶酶原激活物受体(CD87)过表达可减少乳腺癌肿瘤生长及肺转移。
Cancer Gene Ther. 2000 Feb;7(2):292-9. doi: 10.1038/sj.cgt.7700144.
4
Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.尿激酶型纤溶酶原激活剂、其受体及纤溶酶原激活剂抑制剂-1在胃癌细胞中的表达及幽门螺杆菌的作用
Scand J Gastroenterol. 2005 Jul;40(7):783-93. doi: 10.1080/00365520510015665.
5
The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.环氧化酶2-前列腺素E2通路对幽门螺杆菌诱导胃癌细胞中尿激酶型纤溶酶原激活物系统的影响
Helicobacter. 2008 Jun;13(3):174-82. doi: 10.1111/j.1523-5378.2008.00597.x.
6
[uPA expression of gastric cancer cell lines and its correlation with peritoneal seeding].[胃癌细胞系的尿激酶型纤溶酶原激活剂表达及其与腹膜种植的相关性]
Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):13-5.
7
Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.尿激酶受体在人表皮样癌细胞系(HEp3)中的过表达增加了在绒毛尿囊膜上以及在严重联合免疫缺陷小鼠体内的致瘤性。
Int J Cancer. 1998 Jul 17;77(2):257-63. doi: 10.1002/(sici)1097-0215(19980717)77:2<257::aid-ijc15>3.0.co;2-8.
8
Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.稳定表达尿激酶型纤溶酶原激活剂氨基末端片段的人胶质母细胞瘤细胞侵袭特性的调节
Oncogene. 2002 Nov 7;21(51):7824-30. doi: 10.1038/sj.onc.1205893.
9
Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.槲皮素通过调节NF-κb、PKC-δ、ERK1/2和AMPKα中断uPA/uPAR功能,对胃癌细胞具有抗转移作用。
Integr Cancer Ther. 2018 Jun;17(2):511-523. doi: 10.1177/1534735417696702. Epub 2017 Mar 9.
10
[Relationship between urokinase-type plasminogen activator expression and peritoneal metastatic potency in different gastric cancer cell lines].[不同胃癌细胞系中尿激酶型纤溶酶原激活物表达与腹膜转移潜能的关系]
Zhonghua Wei Chang Wai Ke Za Zhi. 2005 May;8(3):249-51.

引用本文的文献

1
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription.转化生长因子-β(TGF-β)诱导纤溶酶原激活物抑制剂-1(PAI-1)启动子中p53/ Smads复合物形成以激活转录。
Sci Rep. 2016 Oct 19;6:35483. doi: 10.1038/srep35483.
2
Morphology and infectivity of virus that persistently caused infection in an AGS cell line.在AGS细胞系中持续引起感染的病毒的形态学和感染性。
Med Mol Morphol. 2011 Dec;44(4):213-20. doi: 10.1007/s00795-010-0530-3. Epub 2011 Dec 17.
3
Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer.基质金属蛋白酶-2 mRNA表达与人胃癌临床病理、尿激酶型纤溶酶原激活物系统参数及预后的关系
World J Gastroenterol. 2005 Jun 7;11(21):3222-6. doi: 10.3748/wjg.v11.i21.3222.
4
Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray.利用cDNA微阵列分析胰腺癌的基因表达谱。
World J Gastroenterol. 2003 Apr;9(4):818-23. doi: 10.3748/wjg.v9.i4.818.

本文引用的文献

1
The plasminogen activation system in tumor growth, invasion, and metastasis.肿瘤生长、侵袭和转移中的纤溶酶原激活系统。
Cell Mol Life Sci. 2000 Jan 20;57(1):25-40. doi: 10.1007/s000180050497.
2
Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.尿激酶型纤溶酶原激活剂:多种癌症中的一种预后标志物。
J Surg Oncol. 1999 Jun;71(2):130-5. doi: 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>3.0.co;2-9.
3
Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma.基质细胞衍生的尿激酶型纤溶酶原激活剂在胃癌中的预后影响。
Cancer. 1999 Mar 1;85(5):1033-8.
4
Urokinase is a positive regulator of epidermal proliferation in vivo.尿激酶在体内是表皮增殖的正向调节因子。
J Invest Dermatol. 1999 Feb;112(2):240-4. doi: 10.1046/j.1523-1747.1999.00494.x.
5
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma.在低分化浆液性卵巢癌中,尿激酶型纤溶酶原激活剂(u-PA)的高组织含量与u-PA mRNA的高基质表达相关。
Int J Cancer. 1998 Dec 18;79(6):588-95. doi: 10.1002/(sici)1097-0215(19981218)79:6<588::aid-ijc6>3.0.co;2-w.
6
Proteases as prognostic markers in cancer.蛋白酶作为癌症的预后标志物
Clin Cancer Res. 1996 Apr;2(4):613-8.
7
uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?尿激酶型纤溶酶原激活物、尿激酶型纤溶酶原激活物受体、纤溶酶原激活物抑制剂-1:蛋白水解、黏附及趋化途径的关键交汇点?
Immunol Today. 1997 Sep;18(9):415-7. doi: 10.1016/s0167-5699(97)01121-3.
8
The urokinase-type plasminogen activator system in cancer metastasis: a review.癌症转移中的尿激酶型纤溶酶原激活物系统:综述
Int J Cancer. 1997 Jul 3;72(1):1-22. doi: 10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z.
9
Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.尿激酶型纤溶酶原激活剂及其受体在人胃癌细胞系中的共表达与其侵袭性和致瘤性相关。
Int J Cancer. 1997 May 29;71(5):867-73. doi: 10.1002/(sici)1097-0215(19970529)71:5<867::aid-ijc27>3.0.co;2-3.
10
Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.尿激酶与尿激酶受体:与人膀胱癌细胞系体外侵袭性的关联。
J Natl Cancer Inst. 1997 May 21;89(10):709-17. doi: 10.1093/jnci/89.10.709.